Manufacturing and Production
Concordia founder resigns and will step down once replacement found
October 25, 2016 Manufacturing and Production CEO, Concordia, Mark Thompson, Valeant
Colombian pharma market to break $7 billion by 2020
October 24, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Colombia, market report
Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug
October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma
The Pharmafocus guide to the US presidential election 2016
October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing US election, feature
Novartis in collaboration deal worth potential $1.2 billion with Cerulean
October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis
Celgene’s Otezla approved by NICE for chronic plaque psoriasis
October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla
MSD’s antiviral drug hits endpoint targets in Phase III trials
October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant
Oxford Genetics boosts cell/gene therapy R&D with new facility
October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion
Recipharm to open largest Nordic GLP bioanalysis lab
October 19, 2016 Manufacturing and Production, Research and Development Recipharm, Sweden, expansion
Quark to set up “largest biotechnology fund in Canada” for $500m
October 18, 2016 Manufacturing and Production, Research and Development Canada, Quark Venture, Vancouver, fund
Research suggests that anti-inflammatory drugs may offer alternative to anti-depressants
October 18, 2016 Manufacturing and Production University of Cambridge, anti-cytokine, anti-inflammatory, depression
IBM and Quest forge precision cancer treatment partnership
October 18, 2016 Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology
Pfizer sets release date for rival to J&J’s blockbuster drug
October 18, 2016 Manufacturing and Production J&J, JJ, Johnson & Johnson, Pfizer, Remicade, inflectra
Regeneron and Teva’s experimental drug halted by FDA clinical hold
October 17, 2016 Manufacturing and Production Regeneron, Teva, back pain, osteoarthritis
Wickham Laboratories Announces Renewal of FDA Accreditation
October 17, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
